Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors

Details 詳細情報について

• CRID

  1360861403900928256

• DOI

  10.1016/j.pharmthera.2022.108272

• ISSN

  01637258

• Web Site

  https://api.elsevier.com/content/article/PII:S0163725822001668?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0163725822001668?httpAccept=text/plain

• Data Source

  • Crossref
  • KAKEN